Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Acellular dermal matrix (ADM) is a biologically derived product, which is devoid of cells. Acellular dermal matrices were initially used in the resurfacing of burn injuries, abdominal wall repair, tympanic membrane replacement, dural repairs, and gingival grafting. Now ADMs are mostly used in breast surgery and plastic surgery. Also, acellular dermal matrices has a wide application in the management of acute wounds such as burns, traumatic wounds, cancer, and infections, they are also used in the management of chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcer, and others and they are also used in the most of the reconstruction procedures such as abdominal wall procedures, which include hernia repair, breast procedures include breast augmentation, orthopedic procedures, and others.

The global acellular dermal matrices market is estimated to be valued at US$ 7,014.0 million in 2021 and is expected to exhibit a CAGR of 12.1% over the forecast period (2021-2028).

Figure 1. Global Acellular Dermal Matrices Market Value (US$ Mn), and Y-o-Y Growth (%), 2018-2028

Acellular Dermal Matrices  | Coherent Market Insights

Increasing number of product launches by key playe rs are expected to drive the market growth over the forecast period.

The key players operating in the global acellular dermal matrices market are focusing on launches and approvals of technologically advanced acellular dermal matrices in the market, which is expected to drive the market growth over the forecast period. For instance, in April 2021, MedSkin Solutions Dr. Suwelack AG, a Germany-based specialized biotech company, launched two new MatriDerm products, MatriDerm Flex Dermal Matrix and MatriDerm Fenestrated Dermal Matrix. The two new products are introduced as an extension of MatriDerm’s product portfolio that offers more flexibility to surgeons for the treatment of complex wounds when it comes to one- and two-stage surgical procedures, which utilizes a split-thickness skin graft.

request-sample

Acellular Dermal Matrices Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 7,014.0 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 12.1% 2028 Value Projection: US$ 15,648.1 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Origin: Human Dermis, Porcine Dermis, Bovine Dermis
  • By Application: Acute Wounds:(Burns, Trauma, Cancers, Infections), Chronic Wounds:(Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcer, and Others), Reconstruction Procedures:(Abdominal Wall Procedures, Breast Procedures, Orthopedic Procedures,  and Others)
  • By Place of Setting: Hospitals(In- patient  and Out- patient), Ambulatory Surgical Centers, Office Based
Companies covered:

Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, CG bio Inc., and Marine Polymer Technologies, Inc.

Growth Drivers:
  • The rising number of surgeries
  • Increasing product launches and approvals
Restraints & Challenges:
  • Complications of acellular dermal matrices in breast surgeries and plastic surgeries
  • Product recalls

Figure 2. Global Acellular Dermal Matrices Market Share (%), by Application, 2021

Acellular Dermal Matrices  | Coherent Market Insights

Global Acellular Dermal Matrices market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe. The coronavirus (COVID 19) pandemic and lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. Private healthcare sector is one of the sectors, which is majorly impacted by the COVID-19 pandemic. Therefore, the governments and government agencies globally are taking various initiatives to combat the spread of COVID-19.

For instance, the Australian Society of Plastic Surgeons (ASPS), the Australian government organization, and BreastSurgANZ announced various guidelines and regulations for reconstruction procedures. These guidelines included surgeons to take informed consent from patients for performing reconstructive surgery during COVID-19 pandemic, inform about the potential consequences of the surgery done during COVID-19 to the patient and others, to delay the reconstruction procedures if not urgent, to delay immediate autologous flap reconstruction for breast reconstruction. While the regulations stated that the reconstructive surgeons should address only the cancer-related surgeries during COVID-19.

Global Acellular Dermal Matrices market: Restraint

Complications and side effects associated with acellular dermal matrices in breast and plastic surgery is expected to restraint growth of the global acellular dermal matrices market over the forecast period. According to the article published in Plastic and Reconstructive Surgery Journal in February 2019, in the U.S., the rate of plastic surgeries are high as compared to other countries. Moreover, the rate of side-effects and complications associated with plastic surgery such as skin necrosis are caused in 8-15% of the patients undergoing plastic surgery.

Key Players

Major players operating in the global acellular dermal matrices market include Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, CG bio Inc., and Marine Polymer Technologies, Inc.

Acellular dermal matrices are generated by decellularization process, which leads to the removal of the cells and preserving of the extracellular matrix. The extracellular matrix ones implanted in the required area, serves as the scaffold for the donor cells. The donor cells help in the revascularization, which in turn generates a new tissue.

Market Dynamics:

The increasing prevalence of breast cancer among the women population is expected to increase the rates of masectomy, which in turn is expected to drive growth of the acellular dermal matrices market growth over the forecast period. For instance, in 2019, according to the World Health Organization (WHO), in India, breast cancer accounts for around 2.09 million cases and 627,000 deaths. It is the most common type of cancer in India and accounts for around 14% of all the cancers in women. It has been estimated that, in India, the incidence rate increases in early thirties and are at its peak at the ages 50-64 years.

Increasing availability of the acellular dermal matrices products in different countries is expected to increase the customer base, which in turn will drive the global acellular dermal matrices market growth over the forecast period. For instance, in 2016, Acelity L.P. Inc., a wound care and regenerative medicine company launched ALLODERM SELECT DUO regenerative tissue matrix in the U.S. The launch will increase the availability of the tissue matrix for the U.S. population undergoing bilateral breast reconstruction.

Key features of the study:

  • This report provides an in-depth analysis of global acellular dermal matrices market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2020 – 2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global acellular dermal matrices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include Zimmer Biomet, Stryker Corporation, Staumann, Allergan, Inc., Conmed, Integra LifeSciences Corporation, Aziyo Biologics, Hospital Innovations,  Medtronic, Inc., Synthes, Inc., Gunze Corp., Cook Medical Incorporated, C. R. Bard, Inc., and HANS BIOMED CORP.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global acellular dermal matrices market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the acellular dermal matrices market

Detailed Segmentation:

  • Global Acellular Dermal Matrices Market, By Material Type:
    • Polyhydroxyalkanoate (PHA)
    • Silicone
    • Dispersants
    • Others
  • Global Acellular Dermal Matrices Market, By Tissue Origin:
    • Human
    • Porcine
    • Bovine
    • Others
  • Global Acellular Dermal Matrices Market, By Application:
    • Orthopedics
    • Plastic Surgery
    • General Surgery
    • Repair and Replacement of Tissue (Wound Coverage)
    • Dental
    • Others
  • Global Acellular Dermal Matrices Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
      • By Material Type:
        • Polyhydroxyalkanoate (PHA)
        • Silicone
        • Dispersants
        • Others
      • By Tissue Origin
        • Human
        • Porcine
        • Bovine
        • Others
      • By Application
        • Orthopedics
        • Plastic Surgery
        • General Surgery
        • Repair and Replacement of Tissue (Wound Coverage)
        • Dental
        • Others
        • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Material Type:
        • Polyhydroxyalkanoate (PHA)
        • Silicone
        • Dispersants
        • Others
      • By Tissue Origin
        • Human
        • Porcine
        • Bovine
        • Others
      • By Application
        • Orthopedics
        • Plastic Surgery
        • General Surgery
        • Repair and Replacement of Tissue (Wound Coverage)
        • Dental
        • Others
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Material Type:
        • Polyhydroxyalkanoate (PHA)
        • Silicone
        • Dispersants
        • Others
      • By Tissue Origin
        • Human
        • Porcine
        • Bovine
        • Others
      • By Application
        • Orthopedics
        • Plastic Surgery
        • General Surgery
        • Repair and Replacement of Tissue (Wound Coverage)
        • Dental
        • Others
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Material Type:
        • Polyhydroxyalkanoate (PHA)
        • Silicone
        • Dispersants
        • Others
      • By Tissue Origin
        • Human
        • Porcine
        • Bovine
        • Others
      • By Application
        • Orthopedics
        • Plastic Surgery
        • General Surgery
        • Repair and Replacement of Tissue (Wound Coverage)
        • Dental
        • Others
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Material Type:
        • Polyhydroxyalkanoate (PHA)
        • Silicone
        • Dispersants
        • Others
      • By Tissue Origin
        • Human
        • Porcine
        • Bovine
        • Others
      • By Application
        • Orthopedics
        • Plastic Surgery
        • General Surgery
        • Repair and Replacement of Tissue (Wound Coverage)
        • Dental
        • Others
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Material Type:
        • Polyhydroxyalkanoate (PHA)
        • Silicone
        • Dispersants
        • Others
      • By Tissue Origin
        • Human
        • Porcine
        • Bovine
        • Others
      • By Application
        • Orthopedics
        • Plastic Surgery
        • General Surgery
        • Repair and Replacement of Tissue (Wound Coverage)
        • Dental
        • Others
  • Company Profiles
    • Zimmer Biomet*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Stryker Corporation
    • Staumann, Allergan, Inc.
    • Conmed
    • Integra LifeSciences Corporation
    • Aziyo Biologics
    • Hospital Innovations
    • Medtronic, Inc.
    • Synthes, Inc.
    • Gunze Corp.
    • Cook Medical Incorporated
    • R. Bard, Inc.
    • HANS BIOMED CORP.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Origin
      • Market Snapshot, By Application
      • Market Snapshot, By Place of Setting
      • Market Snapshot, By Region
      • Market Opportunity Map
  3. Global Acellular Dermal Matrices Market Insights
    • Drivers
    • Restraints
    • Opportunity
    • Impact Analysis
    • Regulatory Scenario
    • PEST Analysis
    • Key Developments
    • Technological Advancement
    • Product Launch/Approvals
    • Acquisition, Collaboration & Agreements
    • Market Share Analysis
    • Brand Analysis
  4. Global Acellular Dermal Matrices Market - Impact of Coronavirus (Covid-19) Pandemic
    • Impact on Supply and Demand
    • Impact on Procedures
    • Government Initiatives
  5. Global Acellular Dermal Matrices Market, By Origin, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
    • Human Dermis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Porcine Dermis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Bovine Dermis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
  6. Global Acellular Dermal Matrices Market, By Application, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Acute Wounds
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
        • Burns
        • Trauma
        • Cancers
        • Infections
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Chronic Wounds
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
        • Diabetic Foot Ulcers
        • Venous Leg Ulcers
        • Pressure Ulcer
        • Others
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Reconstruction Procedures
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
        • Abdominal Wall Procedures
        • Breast Procedures
        • Orthopedic Procedures
        • Others
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
  7. Global Acellular Dermal Matrices Market, By Place of Setting, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
        • In- patient
        • Out- patient
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
    • Office Based
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
  8. Global Acellular Dermal Matrices Market, By Region, 2017 – 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Region at Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Place of Setting, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Place of Setting, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Place of Setting, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Place of Setting, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth,  By Place of Setting, 2017–2028, (US$ Mn)
      • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Snapshot
    • Company Profiles
      • Integra LifeSciences Corporation
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • AbbVie Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Johnson & Johnson
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • HansBioMed
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Becton, Dickinson and Company
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Cook Group
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Smith & Nephew Plc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Reprise Biomedical
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Organogenesis Holdings Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Tissue Regenix
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • LifeNet Health
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Zimmer Biomet Holdings, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Stryker Corporation
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • MiMedx Group
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • PolyNovo Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Fidia Pharma USA Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Baxter International Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • In2Bones Global
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • BioHorizons, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Harbor MedTech, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • MLM Biologics Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Geistlich Pharma AG
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Olaregen Therapeutix, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • EnColl Corporation
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Kerecis limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • DSM
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • ACell Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • 3M
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Cell Constructs I, LLC
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • CG bio Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Marine Polymer Technologies, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
  10. Section
    • Research Methodology
    • About us

*Browse 35 market data tables and 31 figures on "Acellular Dermal Matrices Market” - Global forecast to 2028

FAQgrowicon

Frequently Asked Questions

The global acellular dermal matrices market size is estimated to be valued at US$ 7,014.0 Million in 2021 and is expected to exhibit a CAGR of 12.1% between 2021 and 2028.
The rising number of surgeries and increasing product launches & approvals are major driving factors for the market.
Reconstruction procedures is the leading application segment in the market.
Complications of acellular dermal matrices in breast surgery & plastic surgery and the product recalls are the major factor restraining growth of the market.
Major players operating in the market include Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, CG bio Inc., and Marine Polymer Technologies, Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner